These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 17118686
1. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma. Morice AH, Hochmuth L, Ekelund J, Thorén A, Puterman AS. Pulm Pharmacol Ther; 2008; 21(1):32-9. PubMed ID: 17118686 [Abstract] [Full Text] [Related]
2. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L. Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405 [Abstract] [Full Text] [Related]
3. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M. Drugs; 2008; 68(14):1975-2000. PubMed ID: 18778120 [Abstract] [Full Text] [Related]
4. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE, Noonan MJ. J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [Abstract] [Full Text] [Related]
5. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS. Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902 [Abstract] [Full Text] [Related]
6. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. Kerwin EM, Oppenheimer JJ, LaForce C, Parasuraman B, Miller CJ, O'Dowd L, Goldman M. Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129 [Abstract] [Full Text] [Related]
14. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M. J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221 [Abstract] [Full Text] [Related]
15. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L. Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051 [Abstract] [Full Text] [Related]
16. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. Peters SP, Prenner BM, Mezzanotte WS, Martin P, O'Brien CD. Allergy Asthma Proc; 2008 Mar; 29(5):499-516. PubMed ID: 18694544 [Abstract] [Full Text] [Related]